SiteOne Therapeutics competitors
SiteOne Therapeutics Competitors include Cannabis Sativa, CTD Holdings, Enanta Pharmaceuticals and Endologix.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  SiteOne Therapeutics SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids |  Cannabis Sativa Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. |  CTD Holdings CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases. |  Enanta Pharmaceuticals Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs. |  Endologix Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders. |
Founding Date | Founding Date 2010 | Founding Date 2012 | Founding Date 1990 | Founding Date 1998 | Founding Date 1992 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bozeman, US HQ | Locations Mesquite, US HQ | Locations Alachua, US HQ | Locations Watertown, US HQ | Locations Irvine, US HQ Rosmalen, NL |
Employees | Employees N/A | Employees 6200% increase | Employees 456% decrease | Employees 89 | Employees 675 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 56.8 m | Valuation ($) 35.5 m | Valuation ($) 2 b | Valuation ($) 56.5 m |
Twitter followers | Twitter followers N/A | Twitter followers 107 | Twitter followers N/A | Twitter followers N/A | Twitter followers 242 |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $11.6k (FY, 2015) | Revenue (est.) N/A | Revenue (est.) $206.6m (FY, 2018) | Revenue (est.) $181.2m (FY, 2017) |
Cost of goods | Cost of goods N/A | Cost of goods $5.8k (FY, 2015) | Cost of goods $132.9k (FY, 2017) | Cost of goods N/A | Cost of goods $59.8m (FY, 2017) |
Gross profit | Gross profit N/A | Gross profit $5.8k (FY, 2015) | Gross profit N/A | Gross profit N/A | Gross profit $121.3m (FY, 2017) |
Net income | Net income N/A | Net income ($7.4m) (FY, 2015) | Net income ($3.8m) (FY, 2017) | Net income $72m (FY, 2018) | Net income ($66.4m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised $ 1.7m | Total funding raised $ 9.2m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Cannabis Sativa
HQ
Mesquite, US
Employees
6
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
View companyCTD Holdings
HQ
Alachua, US
Employees
4
CTD Holdings, Inc., is a biotechnology company that develops cyclodextrin-based products for the treatment of diseases.
View companyEnanta Pharmaceuticals
HQ
Watertown, US
Employees
89
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
View companyEndologix
HQ
Irvine, US
Employees
675
Endologix is a developer and manufacturer of minimally invasive treatments for aortic disorders.
View company